VANCOUVER, British Columbia, May 3, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX-V:QLT) ("QLT" or the "Company") announced today positive preliminary results from its Phase 1b proof-of-concept ...
VANCOUVER, B.C., Sept. 12, 2014 -- QLT Inc. (QLTI) (QLT.TO) ("QLT" or the "Company") today announced positive final results from its international, multi-center, Phase 1b clinical trial of repeated ...
MALVERN, Pa., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (OCGN) (Ocugen or the Company), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results